CSIMarket
 
Taro Pharmaceutical Industries Ltd  (NYSE: TARO)
Other Ticker:  
 
 

TARO's Market share relative to its competitors, as of Q1 2023

As of Q1 2023 (Revenue in Millions of $)

Date modified: 2025-05-15T08:34:00+00:00




 
COMPANY NAME REVENUES
12 Months Ending
Q1 2023
MARKET SHARE
12 Months
Q1 2023
MARKET SHARE
MRQ
Q1 2023
MARKET SHARE
A Quarter Before
Q4 2022
Taro Pharmaceutical Industries Ltd 572.95 0.22% 0.22 % 0.00 %
Johnson and Johnson 89,331.00 34.93% 34.96% 34.55%
Bristol myers Squibb Company 47,636.00 18.63% 17.89% 18.94%
Abbott Laboratories 42,344.00 16.56% 16.54% 16.84%
Amgen Inc 33,424.00 13.07% 14.51% 13.05%
Teva Pharmaceutical Industries Limited 16,617.00 6.50% 6.21% 6.49%
Viatris Inc 14,330.20 5.60% 5.20% 5.41%
Perrigo Company Plc 4,334.30 1.69% 1.67% 1.75%
Dr Reddy s Laboratories Limited 3,350.00 1.31% 1.31% 0.00%
Amneal Pharmaceuticals Inc 2,868.80 1.12% 1.11% 1.25%
Myovant Sciences Ltd 379.11 0.15% 0.16% 0.16%
Mannkind Corporation 297.60 0.12% 0.13% 0.12%
Puma Biotechnology Inc 232.71 0.09% 0.07% 0.09%
Allarity Therapeutics Inc 23.79 0.01% 0.00% 0.00%
Immuron Limited 1.48 0.00% 0.00% 0.00%
Therapeuticsmd Inc 1.41 0.00% 0.00% 0.00%
Medicinova Inc 0.00 0.00% 0.00% 0.00%
Biophytis Sa 0.00 0.00% 0.00% 0.00%
SUBTOTAL 255,744.35 100% 62,627.58 100%



TARO's Market share relative to its competitors, as of Q1 2023 within the Major Pharmaceutical Preparations Industry
As of Q1 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2023
MARKET SHARE
12 Months Ending
Q4 2022
MARKET SHARE
MRQ
Q1 2023
MARKET SHARE

Q4 2022
Taro Pharmaceutical Industries Ltd 0.26% 0.25% 0.26 % 0.25 %
Johnson and Johnson 40.18% 40.02% 40.89% 39.73%
Bristol myers Squibb Company 21.43% 21.76% 20.92% 21.78%
Abbott Laboratories 19.05% 18.90% 19.35% 19.36%
Teva Pharmaceutical Industries Limited 7.47% 7.45% 7.27% 7.47%
Viatris Inc 6.45% 6.64% 6.08% 6.22%
Perrigo Company Plc 1.95% 1.97% 1.95% 2.01%
Dr Reddy s Laboratories Limited 1.51% 1.35% 1.51% 1.35%
Amneal Pharmaceuticals Inc 1.29% 1.26% 1.30% 1.43%
Myovant Sciences Ltd 0.17% 0.15% 0.19% 0.18%
Mannkind Corporation 0.13% 0.13% 0.15% 0.14%
Puma Biotechnology Inc 0.10% 0.10% 0.09% 0.10%
Allarity Therapeutics Inc 0.01% 0.01% 0.00% 0.00%
Immuron Limited 0.00% 0.00% 0.00% 0.00%
Therapeuticsmd Inc 0.00% 0.00% 0.00% 0.00%
Medicinova Inc 0.00% 0.00% 0.00% 0.00%
Biophytis Sa 0.00% 0.00% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



TARO's Market share relative to its competitors, as of Q1 2023 within the Healthcare Sector
As of Q1 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2023
MARKET SHARE
12 Months Ending
Q4 2022
MARKET SHARE
MRQ
Q1 2023
MARKET SHARE

Q4 2022
Taro Pharmaceutical Industries Ltd 0.22% 0.22% 0.22 % 0.22 %
Johnson and Johnson 34.93% 34.90% 34.96% 34.55%
Bristol myers Squibb Company 18.63% 18.98% 17.89% 18.94%
Abbott Laboratories 16.56% 16.48% 16.54% 16.84%
Amgen Inc 13.07% 12.78% 14.51% 13.05%
Teva Pharmaceutical Industries Limited 6.50% 6.50% 6.21% 6.49%
Viatris Inc 5.60% 5.79% 5.20% 5.41%
Perrigo Company Plc 1.69% 1.72% 1.67% 1.75%
Dr Reddy s Laboratories Limited 1.31% 1.18% 1.31% 1.18%
Amneal Pharmaceuticals Inc 1.12% 1.10% 1.11% 1.25%
Myovant Sciences Ltd 0.15% 0.13% 0.16% 0.16%
Mannkind Corporation 0.12% 0.11% 0.13% 0.12%
Puma Biotechnology Inc 0.09% 0.09% 0.07% 0.09%
Allarity Therapeutics Inc 0.01% 0.01% 0.00% 0.00%
Immuron Limited 0.00% 0.00% 0.00% 0.00%
Therapeuticsmd Inc 0.00% 0.00% 0.00% 0.00%
Medicinova Inc 0.00% 0.00% 0.00% 0.00%
Biophytis Sa 0.00% 0.00% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



Note: Market share is calculated based on total revenue. To get a more accurate picture of Taro Pharmaceutical Industries Ltd's market divisions, geographic dispersion, segments, products, and services, visit Taro Pharmaceutical Industries Ltd's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com